Intravenous (IV) therapy is the administration of a fluid substance (solution) directly into a vein as a therapeutic treatment. IV therapy, in one form or another, has been around since the 17th century, but was abandoned for several decades because of poor understanding of its nuances.
Testicular cancer is rare, accounting for about 1% of all male cancers. However, testicular cancer is the most common form of cancer in men ages 15-35. Every year, in the U.S., an estimated 8500 men are diagnosed with testicular cancer and 350 die from the disease. That averages to every hour of every day some man hears, âYou have testicular cancer.â. Testicular cancer is one of the most treatable cancers, especially if caught early. If caught at an early stage, before it has spread, the survival rate is almost 100% but if caught at a late stage the rate drops to 80%.
Experts arenât sure why, but the number of new testicular cancer cases diagnosed each year (called incidence) has steadily increased over the last several decades. Testicular cancer is the most common cancer in men 15â29 years of age. The number of men diagnosed with testicular cancer is low before puberty, increases significantly after age 14, peaks around age 30 and then declines by age 60. Testicular cancer is more common in Caucasian men than in men of African or Asian ancestry. It occurs most often in men with a higher socio-economic status.